| Metric | Q4 2022 | Q3 2022 | Q4 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $345M | $390M | $416M | -11.6% | -17.0% |
| Op. Income | $118M | $124M | $184M | -5.5% | -36.2% |
| Gross Margin | 39.1% | 37.8% | 51.7% | 1.3pp | -12.6pp |
| Net Margin | 28.9% | 25.2% | 33.3% | 3.7pp | -4.4pp |
| EPS (Diluted) | $1.93 | $1.90 | $2.68 | 1.6% | -28.0% |
| Free Cash Flow | $110M | $206M | $151M | -46.7% | -27.3% |
| Item | Amount |
|---|---|
| REVENUE | $345M |
| Cost of Revenue | $210M |
| GROSS PROFIT | $135M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $12M |
| Other Expenses | $5M |
| Operating Expenses | $17M |
| Cost & Expenses | $227M |
| OPERATING INCOME | $118M |
| Interest Income | $2M |
| Other Income/Expenses | $2M |
| INCOME BEFORE TAX | $119M |
| Income Tax Expense | $20M |
| Net Income from Continuing Ops | $100M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $100M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $100M |
| D&A | $28M |
| EBIT | $118M |
| EBITDA | $146M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $345M |
| Cost of Revenue | $210M |
| GROSS PROFIT | $135M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $12M |
| Other Expenses | $5M |
| Operating Expenses | $17M |
| Cost & Expenses | $227M |
| OPERATING INCOME | $118M |
| Interest Income | $2M |
| Other Income/Expenses | $2M |
| INCOME BEFORE TAX | $119M |
| Income Tax Expense | $20M |
| Net Income from Continuing Ops | $100M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $100M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $100M |
| D&A | $28M |
| EBIT | $118M |
| EBITDA | $146M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $100M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $3M |
| Deferred Income Tax | $20M |
| Other Non-Cash Items | $26M |
| Change in Working Capital | $44M |
| OPERATING CASH FLOW | $195M |
| Capital Expenditure | -$85M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$13M |
| NET CASH FROM INVESTING | -$98M |
| Net Debt Issuance | -$10M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$3M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$13M |
| FREE CASH FLOW | $110M |
| Net Change in Cash | $84M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $829M |
| Short-Term Investments | $9M |
| Net Receivables | $155M |
| Inventory | $154M |
| Other Current Assets | $24M |
| TOTAL CURRENT ASSETS | $1.2B |
| PP&E (Net) | $828M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $8M |
| Other Non-Current Assets | $20M |
| TOTAL NON-CURRENT ASSETS | $855M |
| TOTAL ASSETS | $2.0B |
| Account Payables | $39M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $13M |
| TOTAL CURRENT LIABILITIES | $153M |
| Long-Term Debt | $303M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $23M |
| Other Non-Current Liabilities | $92M |
| TOTAL NON-CURRENT LIABILITIES | $427M |
| TOTAL LIABILITIES | $581M |
| Common Stock | $539.0K |
| Additional Paid-In Capital | $270M |
| Retained Earnings | $1.2B |
| Treasury Stock | -$51M |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.4B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.4B |
| TOTAL LIABILITIES & EQUITY | $2.0B |
| Total Debt | $336M |
| Net Debt | -$494M |